180869-39-0

Basic information

• Product Name: 4-Pyrimidinecarboxaldehyde, 2-(methylamino)- (9CI)
• Synonyms: 4-Pyrimidinecarboxaldehyde, 2-(methylamino)- (9CI);2-(Methylamino)pyrimidine-4-carboxaldehyde;2-(MethylaMino)pyriMidine-4-carbaldehyde;2-(Methylamino)-4-pyrimidinecarboxaldehyde
• CAS NO: 180869-39-0
• Molecular Formula: C₆H₇N₃O
• Molecular Weight: 137.13928
• Product Categories: PYRIMIDINE;Heterocycle-Pyrimidine series
• Mol File: 180869-39-0.mol

Chemical Properties

• Boiling Point: 305.4 °C at 760 mmHg
• Flash Point: 138.5 °C
• Appearance: /
• Density: 1.281 g/cm³
• Vapor Pressure: 0.000825mmHg at 25°C
• Refractive Index: 1.645
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 2.16±0.10(Predicted)
• CAS DataBase Reference: 4-Pyrimidinecarboxaldehyde, 2-(methylamino)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Pyrimidinecarboxaldehyde, 2-(methylamino)- (9CI)(180869-39-0)
• EPA Substance Registry System: 4-Pyrimidinecarboxaldehyde, 2-(methylamino)- (9CI)(180869-39-0)

Safety Data

• Hazardous Substances Data: 180869-39-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Pyrimidinecarboxaldehyde, 2-(methylamino)(9CI) is used as a key building block in the synthesis of various drugs and pharmaceutical intermediates. Its unique structure allows for the development of new therapeutic agents with potential applications in treating various diseases and medical conditions.
Used in Agrochemical Development:
In the agrochemical industry, 4-Pyrimidinecarboxaldehyde, 2-(methylamino)(9CI) serves as an essential component in the creation of new agrochemicals. Its incorporation into these products can lead to the development of more effective and targeted pest control solutions, contributing to improved crop yields and agricultural sustainability.
Used in Specialty Chemicals Production:
4-Pyrimidinecarboxaldehyde, 2-(methylamino)(9CI) is also utilized in the production of specialty chemicals, where its unique properties can be harnessed to create innovative and high-performance products for various applications, such as in materials science, coatings, and adhesives.
Used in Research and Scientific Applications:
Due to its distinctive chemical structure, 4-Pyrimidinecarboxaldehyde, 2-(methylamino)(9CI) holds potential for use in research and scientific applications. It can be employed in the study of chemical reactions, the development of new synthetic methods, and the exploration of novel chemical compounds with unique properties.
It is crucial to handle 4-Pyrimidinecarboxaldehyde, 2-(methylamino)(9CI) with care, as it may possess potential hazards. Proper safety protocols and regulations should be followed during its use to ensure the safety of individuals and the environment.

InChI:InChI=1/C6H7N3O/c1-7-6-8-3-2-5(4-10)9-6/h2-4H,1H3,(H,7,8,9)

Upstream product

• 180869-38-9 4-(dimethoxymethyl)-N-methylpyrimidin-2-amine 
• 180869-36-7 4-dimethoxymethyl-2-methylsulfanylpyrimidine 
• 874279-26-2 4-(dimethoxymethyl)-2-(methylsulfonyl)pyrimidine 

Downstream Products

• 645419-01-8 2-[(2-methylamino-pyrimidin-4-ylmethyl)-amino]-benzoic acid 

Relevant articles and documents

NEW THIENOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description.

8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS

This invention relates to 8-Heteroarylpurine Mnk2 Inhibitors which are useful for the treatment and prevention of metabolic disorders such as obesity and diabetes.

INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE

The invention relates to compounds of formula (I). Said compounds are suitable for producing medicaments for the prophylaxis and treatment of diseases, the progression of which involves increased activity of IκB kinase.

SUBSTITUTED ANTHRANILIC AMIDE DERIVATIVES AND METHODS OF USE

Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes

Pyrimidine analogs of the pyridinylimidazole class of CSBP/p38 kinase inhibitors were prepared in an effort to reduce the potent inhibition of hepatic cytochrome P450 observed for the pyridinyl compounds. The substitution of pyrimidin-4-yl, 2-methoxypyrimidin-4-yl, or 2- methylaminopyrimidin-4-yl for pyridin-4-yl effectively dissociates CSBP/p38 kinase from P450 inhibition for this series and furthermore achieves an increase in oral activity.

Imidazole compounds, use and process of making

Novel 1,4,5-substituted imidazole compounds and compositions for use in therapy as cytokine inhibitors.

Pyridyl imidazole compounds and compositions

Novel 1, 4, 5-substituted imidazole compounds and compositions for use in therapy as cytokine inhibitors.